Biotechnology is an exciting industry, where technology creates medicine tailored to individuals.
This is seen as the future of healthcare, as instead of being given one size fits all drugs patients can get treatments that will work better for them and fight diseases such as cancer in a way that increases their chances of survival.
As the West’s populations age, this will become even more important.
We interview Carl Harald Janson, the manager of International Biotechnology Trust and a qualified medical doctor. He explains what biotechnology is, how it works and what he looks for when investing in companies that could change healthcare over the next decades.
We also ask him about how this growth-focussed investment trust has started to pay investors a 4 per cent annual dividend.